Axe Compute Inc.【AGPU】

時価総額

$1438万

PER

腫瘍特異的3DモデルとAIを用いた創薬支援の新興企業。患者由来バイオバンク連携の3D腫瘍モデルとChemoFx等の腫瘍プロファイリングサービスを展開。2025年1月のRenovaroとのLOI、2025年3月にRenovaroが467290株を50万ドルで取得。米国中心に展開。

株価業績

サマリーテーブルに戻る

	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Cash and cash equivalents	101,953	16,384	5	1,764,090	766,189	162,152	150,831	678,332	28,202,615	22,071,523	9	734,673
Accounts receivable, net	97,245	57,549	38,283	38,919	137,499	232,602	297,055	256,878	354,196	331,196	333,697	745,566
Inventories	122,175	367,367	231,740	272,208	265,045	241,066	190,156	289,535	387,684	430,493	494,374	385,728
Prepaid expense and other assets	60,588	190,015	271,579	148,637	289,966	318,431	160,222	289,490	513,778	526,801	521,700	306,301
Current assets of discontinued operations	-	-	-	-	-	-	-	-	-	-	-	53,649
Total current assets	381,961	631,315	5	2,608,183	2,371,182	1,451,527	798,264	1,514,235	29,458,273	23,360,013	10	2
Property and equipment, net	158,110	196,479	139,598	101,496	87,716	180,453	1,507,799	3,822,700	2,511,571	1,833,255	1	369,470
Intangibles, net	53,355	73,183	94,987	97,867	95,356	964,495	3,649,412	3,398,101	3,962,118	253,865	252,457	210,113
Lease right-of-use assets	-	-	-	-	-	-	729,745	1,395,351	814,454	211,893	3	2
Other long-term assets	-	-	-	-	-	-	-	116,257	167,065	75,618	124,096	102,509
Total assets	593,426	900,977	6	2,807,546	3,624,254	3,708,999	22,375,510	13,060,436	43,771,271	25,734,644	14	5
Accounts payable	1	2	650,413	220,112	140,462	445,689	3,155,641	1,372,070	1,021,774	943,452	1	1
Note payable	-	-	-	-	-	306,972	-	4,431,925	-	-	150,408	-
Accrued expenses and other liabilities	2	3	864,295	1,346,105	785,215	1,279,114	2,371,633	-	1,262,641	2,229,075	2	1
Derivative liability	-	-	-	-	-	272,745	50,989	294,382	129,480	13,833	1,376	-
Contract liabilities	-	-	-	-	-	23,065	40,384	53,028	186,951	602,073	308,091	304,985
Lease liability	-	-	-	-	-	-	459,481	597,469	639,662	94,237	517,427	572,739
Current liabilities of discontinued operations	-	-	-	-	-	-	-	-	-	-	-	164,771
Total current liabilities	3	6	2	1,574,215	932,340	3,655,527	10,873,928	9,336,921	3,240,508	3,882,670	4	4
Other long-term liabilities	-	-	-	-	-	-	-	235,705	25,415	-	5,459	23,487
Lease liability – net of current portion	-	-	-	-	-	-	270,264	845,129	239,664	86,082	2	2
Total liabilities	4	6	2	1,883,864	932,340	3,655,527	11,144,192	10,417,755	3,505,587	3,968,752	6	5
Series B Convertible Preferred Stock	-	-	18,950	792	792	792	792	792	792	792	792	792
Series B Convertible Preferred Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding as of December 31, 2024, and December 31, 2023	-	206	-	-	-	-	-	-	-	-	-	-
Common stock, $.01 par value, 200,000,000 shares authorized, 6,666,993 and 4,062,853 shares outstanding as of December 31, 2024, and December 31, 2023, respectively	2	30,927	52,063	45,644	69,432	140,917	40,567	198,048	656,146	787,627	40,629	66,670
Additional paid-in capital	-	-	45	47,894,196	57,380,256	63,019,708	93,653,667	110,826,949	167,649,028	174,755,389	176	180
Accumulated deficit	-	-	-40,492,437	-47,018,451	-54,765,045	-63,107,945	-82,498,711	-108,383,108	-128,040,282	-153,777,916	-167,761,883	-180,426,271
Series B Convertible Preferred Stock	-	-	-	-	-	-	792	792	792	792	-	792
Total stockholders’ (deficit) equity	-3,218,454	-5,516,227	4	923,682	2,691,914	53,472	11,231,318	2,642,681	40,265,684	21,765,892	8	-202,610
Total liabilities and stockholders’ (deficit) equity	593,426	900,977	6	2,807,546	3,624,254	3,708,999	22,375,510	13,060,436	43,771,271	25,734,644	14	5